Intratumoral toremifene therapy and tissue distribution in the baboon

Anti-Cancer Drugs

Volumn 9, Issue 2, 1998, Pages 181-189

  Wurz, Gregory T ^a   Mäenpää, Juhani U ^b   Hubbard, Gene B ^c   Cadman, Timothy B ^a   Seymour, Robert C ^d   Soe, Lin ^a   DeGregorio, Michael W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Antiestrogen; Baboon; Intratumoral; Toremifene

Indexed keywords

ANTIESTROGEN; TOREMIFENE;

ADENOCARCINOMA; ARTICLE; BABOON; DRUG EFFICACY; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRATUMORAL DRUG ADMINISTRATION; LYMPHOSARCOMA; MYXOMA; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TISSUE DISTRIBUTION;

EID: 0031890121     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199802000-00010     Document Type: Article

References (33)

1. Hayes DF, Van Zyl JA, Hacking A, et al. Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer. J Clin Oncol 1995; 13: 2556-66.
2. Mäenpää JU, Sipila PEH, Hajba A. Toremifene for recurrent and advanced endometrial carcinoma. Eur J Cancer 1992: 28A: 1768.
3. Valavaara R, Pyrhonen S, Heikkinen M, et al. Toremifene, a new antiestrogenic compound for treatment of advanced breast cancer. Phase II study. Eur J Cancer Clin Oncol 1988; 24: 785-90.
4. Kohler PC, Hamm JT, Wiebe VJ, DeGregorio MW, Shemano I, Tormey DC. Phase I study of the tolerance and pharmacokinetics of toremifene in patients with cancer. Breast Cancer Res Treat 1990; 16: S19-26.
5. Wiebe VJ, Benz CC, Shemano I, Cadman TB, DeGregorio MW. Pharmacokinetics of toremifene and its metabolites in patients with advanced breast cancer. Cancer Chemother Pharmacol 1990; 25: 247-51.
6. DeGregorio MW, Ford JM, Benz CC, Wiebe VJ. Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistance. J Clin Oncol 1989; 7: 1359-64.
7. Mäenpää J, Sipila P, Kangas L, Karnani P, Gronroos M. Chemosensitizing effect of an antiestrogen, toremifene, on ovarian cancer. Gynecol Oncol 1992; 46: 292-7.
8. DeGregorio MW, Mäenpäa JU, Wiebe VJ. Tamoxifen for the prevention of breast cancer: no. In: DeVita VT, Hellman S, Rosenberg SA, eds. Important advances in oncology 1995. Philadelphia, PA: Lippincott 1995: 175-85.
9. Mäenpää J, Dooley T, Wurz G, et al. Topical toremifene: a new approach for cutaneous melanoma? Cancer Chemother Pharmacol 1993; 32: 392-5.
10. Soe L, Wurz GT, Mäenpää JU, et al. Tissue distribution of transdermal toremifene. Cancer Chemother Pharmacol 1997; 39: 513-20
11. Chen HS, Gross JF. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 1980; 64: 31-40.
12. Gadeholt G, Gothlin JH. Intraarterial doxorubicin infusion treatment with and without occlusion of the renal artery in rabbit renal VX-2 carcinoma. Acta Radiologica 1987; 28: 467-1.
13. Krementz ET. Lucy Wortham James Lecture. Regional perfusion. Current sophistication, what next? Cancer 1986; 57: 416-32.
14. Kroin JS. Intrathecal drug administration. Present use and future trends. Clin Pharmacokinet 1992; 22: 319-26.
15. Markman M. Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity. Cancer Treat Rev 1987; 13: 219-42.
16. ivraghi T, Vettori C, Lazzaroni S. Liver metastases: results of percutaneous ethanol injection in 14 patients. Radiology 1991; 179: 709-712.
17. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 1992; 69: 925-9.
18. Shiina S, Tagawa K, Unuma T, Terano A. Percutaneous ethanol injection therapy for the treatment of hepatocellular carcinoma. Am J Roentgenol 1990; 154: 947-51.
19. Shiina S, Tagawa T, Unuma T, et al. Percutaneous ethanol injection therapy of hepatocellular carcinoma: analysis of 77 patients. Am J Roentgenol 1990; 155: 1221-6.
20. Taavitsainen M, Vehmas T, Kauppila R. Fatal liver necrosis following percutaneous ethanol injection for hepatocellular carcinoma. Abdom Imaging 1993; 18: 357-9.
21. Holmes BC. Administration of cancer chemotherapy agents. In: Dorr RT, Von Hoff DD, eds. Cancer chemotherapy handbook, 2nd edn. Norwalk, CT: Appleton and Lange 1994: 57-94.
22. Holleran WM, Gharbo SA, DeGregorio MW. Quantitation of toremifene and its major metabolites in human plasma by high-performance liquid chromatography following fluorescent activation. Anal Lett 1987; 20: 871-9.
23. Hubbard GB, Mone JP, Allan JS, et al. Spontaneously generated non-Hodgkin's lymphoma in twenty-seven simian T-cell leukemia virus type 1 antibody-positive baboons (Papio species). Lab Anim Sci 1993; 43: 301-9.
24. Elias JM, Margiotta M, Gabore D. Sensitivity and detection efficiency of the peroxidase-antiperoxidase (PAT), avidin-biotin peroxidase complex (ABC), and peroxidase-labeled avidin-biotin (LAB) methods. Am J Clin Pathol 1989; 92: 62-7.
25. Greene GL, Nolan C, Engler JP, Jensen EV. Monoclonal antibodies to human estrogen receptor. Proc Natl Acad Sci USA 1980; 77: 5115-9.
26. Greene GL, Harris K, Bova R, Kinders R, Moore B, Nolan C. Purification of T47D human progesterone receptor and immunohistochemical characterization with monoclonal antibodies. Mol Endocrinol 1988; 2: 714-26.
27. Aspillaga MJ, Morizon G, Avedano I. Dimethyl sulfoxide therapy in severe retardation in mongoloid children. Ann NY Acad Sci 1975; 243: 421-31.
28. Bennett WM, Muther RS. Lack of nephrotoxicity of intravenous dimethylsulfoxide. Clin Toxicol 1981; 18: 615-8.
29. Brobyn RD. The human toxicology of dimethyl sulfoxide. Ann NY Acad Sci 1975; 243: 497-506.
30. Fuks JZ, Egorin MJ, Aisner J, et al. Cyclophosphamide and dimethylsulfoxide in the treatment of squamous carcino ma of the lung. Cancer Chemother Pharmacol 1981; 6: 117-20.
31. Rubin LF. Toxicologic update of dimethyl sulfoxide. Ann NY Acad Sci 1983; 411: 6-10.
32. Shirley SW, Stewart BH, Mirelman S. Dimethyl sulfoxide in treatment of inflammatory genitourinary disorders. Urology 1978; 11: 215-20.
33. Editorial. Treatment of renal amyloidosis. Lancet 1980; i: 1062.